These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The influence of statin medications on prostate-specific antigen levels. Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682 [TBL] [Abstract][Full Text] [Related]
3. The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report. Cyrus-David MS; Weinberg A; Thompson T; Kadmon D J Urol; 2005 Jun; 173(6):1923-5. PubMed ID: 15879782 [TBL] [Abstract][Full Text] [Related]
4. Prostate specific antigen reduction following statin therapy: Mechanism of action and review of the literature. Mener DJ IUBMB Life; 2010 Aug; 62(8):584-90. PubMed ID: 20665620 [TBL] [Abstract][Full Text] [Related]
5. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men. Culp S; Porter M BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868 [TBL] [Abstract][Full Text] [Related]
6. The impact of HMG-CoA reductase therapy on serum PSA. Mener DJ; Cambio A; Stoddard DG; Martin BA; Palapattu GS Prostate; 2010 May; 70(6):608-15. PubMed ID: 19998369 [TBL] [Abstract][Full Text] [Related]
7. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL; Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472 [TBL] [Abstract][Full Text] [Related]
8. Statins and prostate cancer prevention: where we are now, and future directions. Murtola TJ; Visakorpi T; Lahtela J; Syvälä H; Tammela TLj Nat Clin Pract Urol; 2008 Jul; 5(7):376-87. PubMed ID: 18542103 [TBL] [Abstract][Full Text] [Related]
9. Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort. Jacobs EJ; Rodriguez C; Bain EB; Wang Y; Thun MJ; Calle EE Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2213-7. PubMed ID: 17971518 [TBL] [Abstract][Full Text] [Related]
10. Soy consumption and phytoestrogens: effect on serum prostate specific antigen when blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic men. Jenkins DJ; Kendall CW; D'Costa MA; Jackson CJ; Vidgen E; Singer W; Silverman JA; Koumbridis G; Honey J; Rao AV; Fleshner N; Klotz L J Urol; 2003 Feb; 169(2):507-11. PubMed ID: 12544298 [TBL] [Abstract][Full Text] [Related]
11. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening. Hutterer G; Perrotte P; Gallina A; Walz J; Jeldres C; Traumann M; Suardi N; Saad F; Bénard F; Valiquette L; McCormack M; Graefen M; Montorsi F; Karakiewicz PI Eur J Cancer; 2007 May; 43(7):1180-7. PubMed ID: 17292604 [TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy. Coward RM; Simhan J; Carson CC BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450 [TBL] [Abstract][Full Text] [Related]
13. Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States. Cheng I; Yu MC; Koh WP; Pike MC; Kolonel LN; Henderson BE; Stram DO Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1692-6. PubMed ID: 16030103 [TBL] [Abstract][Full Text] [Related]
14. Statins and prostate cancer risk: a case-control study. Shannon J; Tewoderos S; Garzotto M; Beer TM; Derenick R; Palma A; Farris PE Am J Epidemiol; 2005 Aug; 162(4):318-25. PubMed ID: 16014776 [TBL] [Abstract][Full Text] [Related]
15. Physiologic variations of serum testosterone within the normal range do not affect serum prostate-specific antigen. Monath JR; McCullough DL; Hart LJ; Jarow JP Urology; 1995 Jul; 46(1):58-61. PubMed ID: 7541587 [TBL] [Abstract][Full Text] [Related]
16. How statins may increase prostate cancer. Goldstein MR; Mascitelli L; Pezzetta F Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):459. PubMed ID: 18268131 [No Abstract] [Full Text] [Related]
17. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer. Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094 [TBL] [Abstract][Full Text] [Related]
18. Association between statins and prostate tumor inflammatory infiltrate in men undergoing radical prostatectomy. Bañez LL; Klink JC; Jayachandran J; Lark AL; Gerber L; Hamilton RJ; Masko EM; Vollmer RT; Freedland SJ Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):722-8. PubMed ID: 20160265 [TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen: a misused and maligned prostate cancer biomarker. Thompson IM; Tangen CM; Kristal AR J Natl Cancer Inst; 2008 Nov; 100(21):1487-8. PubMed ID: 18957671 [No Abstract] [Full Text] [Related]
20. Body mass index influences prostate-specific antigen in men younger than 60 years of age. Kim YJ; Han BK; Hong SK; Byun SS; Kim WJ; Lee SE Int J Urol; 2007 Nov; 14(11):1009-12. PubMed ID: 17956528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]